| Literature DB >> 26647816 |
Neha Mehrotra1, Ravi Mani Tripathi2.
Abstract
Since the first experiment depicting gene inhibition using RNA interference mechanism, extensive research has been carried out to design targeted delivery systems that use short interfering RNAs (siRNAs) for gene expression regulation. Although several siRNAs loaded nanoparticle systems have reached clinical trial stage, cellular uptake, reticuloendothelial entrapment and endosomal escape still limit the efficacy of these drugs considerably. This review discusses about the RNA interference mechanism, nanostructures being used as non-viral vectors for targeted delivery, limitations of the common delivery systems and the current siRNA-loaded nanoparticle formulations undergoing clinical testing.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26647816 DOI: 10.1049/iet-nbt.2015.0018
Source DB: PubMed Journal: IET Nanobiotechnol ISSN: 1751-8741 Impact factor: 1.847